Fundz

Landos Biopharma, Inc. reported raising $60.3 Million in an initial SEC Form D filing, from an offering of $60.3 Million

PRIVATEAug 23, 2019

Amount Raised

$60.3 Million

$60.3 Million sold, per SEC Form D (first sale Aug 23, 2019)

Round Type

Venture

BlacksburgBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Quick answer

Landos Biopharma, Inc. raised $60.3 Million in a funding round, dated August 23, 2019. Landos Biopharma, Inc. is based in Blacksburg, Virginia, United States.

How much did Landos Biopharma, Inc. raise?
Landos Biopharma, Inc. raised $60.3 Million in a funding round on August 23, 2019.
What does Landos Biopharma, Inc. do?
Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune diseases.
Where is Landos Biopharma, Inc. based and how big is it?
Landos Biopharma, Inc. is based in Blacksburg, Virginia, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Landos Biopharma, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • CUREMARK LLC raised $5.4M on September 11, 2019.
  • vTv Therapeutics Inc. raised $4M (Seed) on July 9, 2019.
  • Renibus Therapeutics raised $3.4M on September 23, 2019.
  • OnKure Therapeutics raised $100K (Seed) on September 20, 2019.
  • Cartesian Therapeutics, Inc. raised $5.8M on September 4, 2019.
  • Entero Therapeutics raised $2.6M (Seed) on August 19, 2019.

Who to call at Landos Biopharma, Inc., and when

A new round usually means Landos Biopharma, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Landos Biopharma, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Landos Biopharma, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Landos Biopharma, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Landos Biopharma, Inc.

Location

1800 KRAFT DRIVE, SUITE 216

Blacksburg, Virginia, United States

About

Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune diseases. Its mission is to create safe and effective oral treatments that address the therapeutic gap in the current treatment paradigm. Landos has a portfolio of novel targets anchoring two libraries of immunometabolic modulation pathways, including four potentially first-in-class, once-daily, oral therapies targeting multiple indications in the immunology space. Landos is currently focused on advancing the clinical development of NX-13 in UC. Landos initiated the NEXUS Phase 2 proof-of-concept trial (NCT05785715) in the second quarter of 2023 and plans to report topline results in the fourth quarter of 2024. For more information, please visit www.landosbiopharma.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Landos Biopharma, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Landos Biopharma, Inc.'s next move

See what Strategic adds

Landos Biopharma, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.